BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year total asset growth rate
Latest
-56.07%
↓ 145% vs avg
Percentile
P3
Near historical low
Streak
2 qtr
Consecutive declineDecelerating
Average
124.36%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -56.07% |
| Q3 2025 | 26.72% |
| Q2 2025 | 70.21% |
| Q1 2025 | -4.81% |
| Q4 2024 | 77.83% |
| Q3 2024 | -3.83% |
| Q2 2024 | -48.44% |
| Q1 2024 | -35.77% |
| Q4 2023 | -29.44% |
| Q3 2023 | -10.41% |
| Q2 2023 | -11.32% |
| Q1 2023 | -12.51% |
| Q4 2022 | -4.42% |
| Q3 2022 | -8.42% |
| Q2 2022 | -3.29% |
| Q1 2022 | -11.19% |
| Q4 2021 | -4.30% |
| Q3 2021 | 244.63% |
| Q2 2021 | 4501.18% |
| Q1 2021 | 1.01% |
| Q4 2020 | -13.29% |
| Q3 2020 | 18.77% |
| Q2 2020 | -8.02% |
| Q1 2020 | 0.36% |
| Q4 2019 | 7.15% |
| Q3 2019 | -62.91% |
| Q2 2019 | 27.85% |
| Q1 2019 | -33.33% |
| Q4 2018 | -38.44% |
| Q3 2018 | -38.39% |
| Q2 2018 | 365.43% |
| Q1 2018 | -39.48% |
| Q4 2017 | -19.53% |
| Q3 2017 | 2.85% |
| Q2 2017 | 16.20% |
| Q1 2017 | -16.85% |
| Q4 2016 | 97.01% |
| Q3 2016 | -31.12% |
| Q2 2016 | 101.25% |
| Q1 2016 | -38.39% |